
No. of Pages: 103 | Report Code: TIPRE00017288 | Category: Life Sciences
No. of Pages: 103 | Report Code: TIPRE00017288 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Patient Controlled Injectors Market – By Product
1.3.2 North America Patient Controlled Injectors Market – By Application
1.3.3 North America Patient Controlled Injectors Market – By Distribution Channel
1.3.4 North America Patient Controlled Injectors Market – By Country
2. North America Patient Controlled Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Patient Controlled Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Patient Controlled Injectors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Patient Controlled Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Preference of Alternative Drug Delivery
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market – North America Analysis
6.1 North America Patient Controlled Injectors Market Revenue Forecasts and Analysis
7. North America Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
7.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Electronic Injector
7.3.1 Overview
7.3.2 North America Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Patient Controlled Injectors Market Analysis – By Application
8.1 Overview
8.2 North America Patient Controlled Injectors Market, By Application 2019-2027 (%)
8.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Patient Controlled Injectors Market Analysis – By Distribution Channel
9.1 Overview
9.2 North America Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)
9.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Patient Controlled Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.7.4 US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.8.4 Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.9.4 Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Patient Controlled Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 West Pharmaceutical Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson and Johnson Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Enable Injections
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 scPharmaceuticals Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 United Therapeutics Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. North America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 6. North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 8. US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 9. US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 12. Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 15. Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Patient Controlled Injectors Market
LIST OF FIGURES
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. North America Patient Controlled Injectors Market Overview
Figure 3. Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)
Figure 6. Patient Controlled Injectors Market - North America PEST Analysis
Figure 7. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 8. North America Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
Figure 10. North America Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Patient Controlled Injectors Market, by Application 2019 & 2027 (%)
Figure 14. North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)
Figure 19. North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 25. US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets